Regeneron : REGN

All Regeneron Articles

246 Articles

Jon C. Ogg | Feb 12, 2014 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Amazon, Control4, Ocwen, Sprint, Veeco, More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, February 12, 2014.…

Jon C. Ogg | Jan 15, 2014 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Intel, ExOne, GameStop, SodaStream and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, January 15.

Jon C. Ogg | Jan 6, 2014 at 9:00 AM EST

Ten Top Growth Stock Ideas for 2014 From Baird

Baird offers an eclectic and interesting list for investors. A top regional firm, it tends to dig a little deeper,…

Jon C. Ogg | Dec 18, 2013 at 8:20 AM EST

Piper Jaffray Top Stocks to Buy for 2014

courtesy of Apple Inc.Like most firms that we cover on Wall Street, Piper Jaffray has updated its top names to…

Lee Jackson | Dec 11, 2013 at 9:00 AM EST

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

ThinkstockCredit Suisse is out and pounding the table that biotechnology cannot be ignored in 2014. Biotech has been the top-performing…

Jon C. Ogg | Nov 21, 2013 at 7:25 AM EST

Solid Biotech Stocks With the Best Revenue Growth for 2014

ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up…

Lee Jackson | Nov 6, 2013 at 8:30 AM EST

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

ThinkstockThe UBS proprietary institutional flow data indicates that hedge funds are increasing exposure to financials and decreasing exposure to health…

Jon C. Ogg | Oct 8, 2013 at 2:47 PM EDT

Market Take: Biotech Suffers Under Government Shutdown Too!

ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such,…

Lee Jackson | Sep 16, 2013 at 8:45 AM EDT

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…

Jon C. Ogg | Aug 22, 2013 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Microsoft, Target, Zynga and More

Jon OggNow that stocks have pulled back and interest rates have risen, investors are looking for more guidance on which…

Jon C. Ogg | Aug 7, 2013 at 6:58 AM EDT

Twelve Bull Market Stocks That Need Stock Splits: Google, Apple, Amazon and More

Stock splits have long been cheered by the investing community. After all, this gives retail investors the chance to get…

Jon C. Ogg | Jul 2, 2013 at 8:45 AM EDT

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for…

Trey Thoelcke | May 16, 2013 at 7:30 AM EDT

Top New Biotech Ideas From PropThink

ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug…

Jon C. Ogg | May 15, 2013 at 8:10 AM EDT

Deutsche Bank Firm on Biotech Stocks to Buy

ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and…

Jon C. Ogg | May 2, 2013 at 8:40 AM EDT

Top Wall Street Analyst Upgrades: Allergan, Arch, Petrobras and More

Investors and traders are always looking to find fresh research ideas that will lead to higher income or more profits.…

1 … 12 13 14 15 16 17

Regeneron : REGN

All Regeneron Articles

Top Analyst Upgrades and Downgrades: Amazon, Control4, Ocwen, Sprint, Veeco, More

Top Analyst Upgrades and Downgrades: Intel, ExOne, GameStop, SodaStream and More

Ten Top Growth Stock Ideas for 2014 From Baird

Piper Jaffray Top Stocks to Buy for 2014

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

Solid Biotech Stocks With the Best Revenue Growth for 2014

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

Market Take: Biotech Suffers Under Government Shutdown Too!

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Top Analyst Upgrades and Downgrades: Microsoft, Target, Zynga and More

Twelve Bull Market Stocks That Need Stock Splits: Google, Apple, Amazon and More

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Top New Biotech Ideas From PropThink

Deutsche Bank Firm on Biotech Stocks to Buy

Top Wall Street Analyst Upgrades: Allergan, Arch, Petrobras and More

What $5,800 a Month Really Looks Like in Retirement at 66 When Half Your Income Is Pension and Half Is RMD

Medicare’s Hidden Two-Year Lookback Rule Catches Retirees Who Inherit IRAs Before 65

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

What $5,800 a Month Really Looks Like in Retirement at 66 When Half Your Income Is Pension and Half Is RMD

Medicare's Hidden Two-Year Lookback Rule Catches Retirees Who Inherit IRAs Before 65

What $5,800 a Month Really Looks Like in Retirement at 66 When Half Your Income Is Pension and Half Is RMD

Medicare’s Hidden Two-Year Lookback Rule Catches Retirees Who Inherit IRAs Before 65

Regeneron : REGN

All Regeneron Articles

Top Analyst Upgrades and Downgrades: Amazon, Control4, Ocwen, Sprint, Veeco, More

Top Analyst Upgrades and Downgrades: Intel, ExOne, GameStop, SodaStream and More

Ten Top Growth Stock Ideas for 2014 From Baird

Piper Jaffray Top Stocks to Buy for 2014

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

Solid Biotech Stocks With the Best Revenue Growth for 2014

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

Market Take: Biotech Suffers Under Government Shutdown Too!

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Top Analyst Upgrades and Downgrades: Microsoft, Target, Zynga and More

Twelve Bull Market Stocks That Need Stock Splits: Google, Apple, Amazon and More

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Top New Biotech Ideas From PropThink

Deutsche Bank Firm on Biotech Stocks to Buy

Top Wall Street Analyst Upgrades: Allergan, Arch, Petrobras and More

What $5,800 a Month Really Looks Like in Retirement at 66 When Half Your Income Is Pension and Half Is RMD

Medicare’s Hidden Two-Year Lookback Rule Catches Retirees Who Inherit IRAs Before 65

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Featured Reads

What $5,800 a Month Really Looks Like in Retirement at 66 When Half Your Income Is Pension and Half Is RMD

Medicare's Hidden Two-Year Lookback Rule Catches Retirees Who Inherit IRAs Before 65